𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug use in infection control — Is more less?

✍ Scribed by Gail S. Itokazu; R. A. Weinstein

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
345 KB
Volume
21
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of targeted array-based CGH for the
Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: Is less more?
✍ Bassem A. Bejjani; Reza Saleki; Blake C. Ballif; Emily A. Rorem; Kyle Sundin; Aa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

## Abstract Chromosome analysis is an important component to the diagnosis of congenital anomalies, developmental delay, and mental retardation. Routine chromosome analysis identifies aneuploidy and structural rearrangements greater than 5 Mb but cannot identify abnormalities of the telomeric regio

Cefotaxime is more effective than is amp
Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections
✍ Josefina Felisart; Antoni Rimola; Vicente Arroyo; Rosa M. Perez-Ayuso; Enrique Q 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

We compared the effectiveness and incidence of nephrotoxicity of ampicillin-tobramycin and cefotaxime in 73 cirrhotics who had severe bacterial infection. Most of these patients had spontaneous peritonitis and/or bacteremia. Patients were randomly allocated into two groups. Group I included 36 patie

Utilization of elderly donors in living
Utilization of elderly donors in living donor liver transplantation: When more is less?
✍ Murat Dayangac; C. Burcin Taner; Onur Yaprak; Tolga Demirbas; Deniz Balci; Cihan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

An accepted definition of donor exclusion criteria has not been established for living donor liver transplantation (LDLT). The use of elderly donors to expand the living donor pool raises ethical concerns about donor safety. The aims of this study were (1) the comparison of the postoperative outcome

Using controlled clinical trials to lear
Using controlled clinical trials to learn more about acute drug-induced liver injury
✍ Paul B. Watkins; Paul J. Seligman; John S. Pears; Mark I. Avigan; John R. Senior 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Drug-induced liver injury (DILI) is of major interest to hepatologists and clinicians in general, patients, government regulators, and the pharmaceutical industry. Understanding why this form of injury occurs only in certain individuals has major implications for the development and availability of